Millions of Americans take antidepressants. And like all medication they come with side effects. Researchers studied 30 ...
(Alliance News) - Avacta Group PLC on Monday said its lead programme faridoxorubicin showed favourable safety and tolerability in patients with salivary gland cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback